Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00866242
Recruitment Status : Terminated (Reactogenicity met study halting criteria)
First Posted : March 20, 2009
Last Update Posted : April 21, 2017
Information provided by (Responsible Party):
Karen Kotloff, University of Maryland

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2010
  Actual Study Completion Date : February 2010
  Certification/Extension First Submitted : April 20, 2017